This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
mg kg | 1317 |
oxidative stress | 762 |
present document | 713 |
gene expression | 622 |
food safety | 540 |
results suggest | 532 |
amino acid | 507 |
nitric oxide | 500 |
safety authority | 498 |
european food | 498 |
cancer cells | 496 |
present study | 494 |
blood pressure | 481 |
heart failure | 477 |
control group | 476 |
immune system | 458 |
amino acids | 456 |
immune response | 443 |
side effects | 434 |
cell lines | 400 |
cell death | 388 |
inflammatory response | 374 |
endothelial cells | 368 |
cell line | 364 |
important role | 359 |
breast cancer | 356 |
blood flow | 353 |
der schwangerschaft | 352 |
fatty acids | 346 |
air pollution | 341 |
small intestine | 333 |
cell proliferation | 308 |
septic shock | 306 |
nervous system | 300 |
immune function | 296 |
epithelial cells | 295 |
clinical trials | 293 |
smooth muscle | 293 |
heart rate | 289 |
body weight | 287 |
pulmonary hypertension | 283 |
cardiac output | 281 |
gastrointestinal tract | 272 |
research funds | 270 |
may also | 269 |
intensive care | 269 |
necrosis factor | 268 |
reactive oxygen | 261 |
myocardial infarction | 257 |
kg day | 255 |
ng ml | 254 |
growth factor | 251 |
skeletal muscle | 246 |
pomegranate juice | 243 |
output adopted | 242 |
awarded following | 242 |
authority reserves | 242 |
published complying | 242 |
tender procedure | 242 |
conclusions reached | 242 |
issues addressed | 242 |
transparency principle | 242 |
left ventricular | 240 |
results indicate | 238 |
adverse effects | 237 |
escherichia coli | 237 |
animal models | 231 |
without prejudice | 231 |
oral administration | 230 |
bodies identified | 229 |
oxygen species | 227 |
tumor necrosis | 226 |
significantly increased | 225 |
significantly reduced | 225 |
molecular weight | 223 |
protein kinase | 222 |
molecular mechanisms | 221 |
risk factors | 218 |
clinical signs | 218 |
significantly higher | 216 |
molar mass | 212 |
type diabetes | 210 |
fatty acid | 208 |
dependent manner | 206 |
lung injury | 206 |
dna damage | 206 |
controlled trial | 205 |
lipid peroxidation | 205 |
cancer cell | 204 |
mrna expression | 201 |
pg ml | 201 |
antioxidant activity | 200 |
inflammatory cytokines | 200 |
mg ml | 199 |
critically ill | 198 |
mass spectrometry | 196 |
statistically significant | 195 |
cell cycle | 193 |
graduate school | 193 |
stem cells | 192 |
peripheral blood | 191 |
spinal cord | 191 |
antiviral effect | 190 |
pulmonary vascular | 190 |
beneficial effects | 188 |
systematic review | 186 |
small intestinal | 186 |
protein expression | 186 |
cell surface | 184 |
lung cancer | 184 |
mouse model | 183 |
plasma membrane | 183 |
converting enzyme | 182 |
respiratory tract | 182 |
recent studies | 181 |
inhibitory effect | 181 |
two groups | 178 |
diabetes mellitus | 177 |
randomized controlled | 177 |
transcription factor | 175 |
protective effect | 174 |
coronary artery | 174 |
organ failure | 173 |
data suggest | 173 |
human health | 172 |
blood samples | 171 |
immune responses | 170 |
acute respiratory | 169 |
results showed | 168 |
rheumatoid arthritis | 167 |
significant difference | 167 |
prostate cancer | 167 |
widely used | 166 |
punica granatum | 166 |
significant differences | 165 |
mechanical ventilation | 164 |
central nervous | 163 |
doc id | 161 |
signaling pathways | 161 |
cord uid | 161 |
drug delivery | 161 |
gut microbiota | 160 |
previous studies | 160 |
plant mirnas | 160 |
significant increase | 158 |
insulin resistance | 158 |
wild type | 157 |
heart disease | 156 |
kg cu | 155 |
plasma levels | 154 |
wide range | 153 |
calcium propionate | 151 |
receptor antagonist | 151 |
mammary gland | 151 |
cell types | 151 |
may contribute | 151 |
results show | 150 |
renal failure | 150 |
angiotensin ii | 149 |
western blot | 148 |
antimicrobial activity | 148 |
vascular resistance | 148 |
ang ii | 147 |
may result | 147 |
cytokine production | 147 |
findings suggest | 146 |
adhesion molecules | 146 |
commonly used | 146 |
two different | 146 |
immune cells | 146 |
protective effects | 146 |
flow cytometry | 145 |
significantly decreased | 144 |
cardiovascular disease | 144 |
bone marrow | 144 |
zinc supplementation | 143 |
cell viability | 143 |
may occur | 142 |
adipose tissue | 142 |
high levels | 142 |
binding protein | 141 |
dairy cows | 140 |
signaling pathway | 140 |
wound healing | 139 |
risk assessment | 139 |
treatment locations | 139 |
one study | 139 |
signal transduction | 138 |
inflammatory mediators | 137 |
cell membrane | 137 |
antimicrobial peptides | 136 |
colorectal cancer | 136 |
expression levels | 136 |
tumor cells | 135 |
united states | 135 |
pulmonary artery | 134 |
fish oil | 134 |
clinical trial | 134 |
taken together | 134 |
weight loss | 133 |
signi fi | 132 |
care unit | 131 |
another study | 131 |
inhibitory effects | 131 |
dendritic cells | 130 |
ill patients | 130 |
respiratory distress | 128 |
biological activity | 128 |
may cause | 128 |
large intestine | 127 |
antiviral activity | 126 |
cardiac surgery | 126 |
also found | 126 |
antibacterial activity | 126 |
reperfusion injury | 125 |
public health | 125 |
healthy volunteers | 125 |
kg body | 125 |
may play | 125 |
multiple organ | 124 |
free radicals | 124 |
arterial pressure | 123 |
platelet aggregation | 123 |
staphylococcus aureus | 123 |
different types | 123 |
group i | 122 |
wistar rats | 122 |
type i | 121 |
mast cells | 121 |
mononuclear cells | 120 |
significantly lower | 120 |
high concentrations | 120 |
chinese medicine | 119 |
deficient mice | 119 |
guinea pigs | 118 |
animal model | 118 |
gut microbiome | 118 |
allergic rhinitis | 118 |
protein synthesis | 117 |
bei der | 117 |
superoxide dismutase | 116 |
cordyceps sinensis | 116 |
per day | 115 |
patients undergoing | 115 |
colon cancer | 115 |
several studies | 115 |
enzyme activity | 114 |
blood glucose | 114 |
muscle cells | 113 |
may lead | 113 |
healthy subjects | 112 |
chronic diseases | 112 |
transgenic mice | 112 |
serum levels | 112 |
diabetic rats | 112 |
rat model | 112 |
traditional chinese | 112 |
die praxis | 112 |
nuclear factor | 112 |
well known | 111 |
vitro studies | 111 |
binding sites | 111 |
cell culture | 111 |
one may | 111 |
distress syndrome | 110 |
long term | 110 |
extracellular matrix | 109 |
lymph nodes | 109 |
stem cell | 108 |
atrial fibrillation | 108 |
also may | 107 |
dairy calves | 107 |
inflammatory effects | 107 |
blood cells | 107 |
exogenous ncrnas | 107 |
electron microscopy | 107 |
free radical | 107 |
acute phase | 107 |
septic patients | 106 |
innate immune | 106 |
cardiovascular diseases | 106 |
oxide synthase | 105 |
increased risk | 105 |
mean age | 105 |
three different | 105 |
veal calves | 105 |
broccoli sprouts | 105 |
inflammatory diseases | 105 |
ms ms | 104 |
clinical studies | 104 |
toxic effects | 104 |
inhibitory activity | 103 |
cancer patients | 103 |
ml kg | 103 |
liver injury | 103 |
mechanisms underlying | 103 |
binding site | 103 |
transcription factors | 102 |
high doses | 102 |
activated protein | 102 |
recent years | 102 |
cell growth | 101 |
guinea pig | 101 |
inflammatory responses | 101 |
arachidonic acid | 101 |
ace inhibitors | 101 |
lactic acid | 101 |
chronic inflammation | 101 |
influenza virus | 101 |
endothelial cell | 100 |
hydrogen peroxide | 100 |
first time | 100 |
metabolic syndrome | 99 |
cell adhesion | 99 |
studies showed | 99 |
arterial blood | 98 |
kg min | 98 |
also known | 98 |
knockout mice | 98 |
significant reduction | 98 |
antioxidant capacity | 98 |
pharmakologie und | 98 |
high affinity | 98 |
data indicate | 97 |
significant decrease | 97 |
key role | 97 |
endothelial dysfunction | 97 |
neurodegenerative diseases | 97 |
ex vivo | 97 |
medicinal plants | 96 |
plasma concentrations | 96 |
protein levels | 96 |
cell migration | 96 |
body mass | 95 |
supporting publication | 95 |
whole blood | 95 |
type ii | 95 |
efsa supporting | 95 |
acute lung | 95 |
large number | 95 |
cancer therapy | 95 |
und toxikologie | 95 |
analysis revealed | 95 |
membrane potential | 94 |
health effects | 94 |
health care | 94 |
inflammatory cells | 94 |
candidate treatment | 94 |
progenitor cells | 94 |
air quality | 93 |
red blood | 93 |
fat diet | 93 |
tissue damage | 93 |
cellular uptake | 93 |
proinflammatory cytokines | 93 |
infectious diseases | 93 |
current study | 92 |
severe acute | 92 |
inflammatory activity | 92 |
apache ii | 92 |
acute coronary | 92 |
cardiopulmonary bypass | 92 |
pregnant women | 92 |
dawley rats | 91 |
ellagic acid | 91 |
receptor antagonists | 91 |
antiviral effects | 91 |
right ventricular | 91 |
recent study | 91 |
radix bupleuri | 91 |
national institute | 89 |
auf die | 89 |
cerebral cortex | 89 |
phenolic compounds | 89 |
microwave exposure | 89 |
liquid chromatography | 89 |
hinweise auf | 89 |
calcium channel | 89 |
climate change | 88 |
oxidative damage | 88 |
treatment effects | 88 |
particle size | 88 |
treatment location | 87 |
nucleic acids | 87 |
beim menschen | 87 |
may provide | 87 |
fold higher | 86 |
group ii | 86 |
previously reported | 86 |
vascular smooth | 86 |
brain injury | 86 |
statistical analysis | 86 |
prefrontal cortex | 86 |
radical scavenging | 85 |
mammalian cells | 85 |
laboratory animals | 85 |
risk factor | 84 |
oxide nanoparticles | 84 |
low dose | 84 |
viral infections | 84 |
mortality rate | 84 |
expression level | 84 |
cassiae semen | 84 |
respiratory syndrome | 83 |
time course | 83 |
biological activities | 83 |
iron oxide | 83 |
lg ml | 83 |
studies suggest | 82 |
low levels | 82 |
action potential | 82 |
even though | 82 |
performed using | 82 |
pomegranate fruit | 82 |
ion channels | 82 |
ace inhibition | 82 |
inflammatory bowel | 82 |
also observed | 82 |
diabetic patients | 82 |
biological effects | 82 |
pulmonary fibrosis | 82 |
mg day | 82 |
lung disease | 81 |
cardiac hypertrophy | 81 |
mrna levels | 81 |
pomegranate extract | 80 |
three groups | 80 |
icu patients | 80 |
antiviral properties | 80 |
bioactive compounds | 80 |
molecular mechanism | 80 |
negative bacteria | 80 |
blot analysis | 80 |
shift workers | 80 |
environmental factors | 80 |
grocery store | 80 |
may help | 79 |
lamina propria | 79 |
significantly different | 79 |
purkinje cells | 79 |
dna methylation | 79 |
intestinal mucosa | 79 |
blood cell | 79 |
density lipoprotein | 79 |
animal studies | 79 |
research institute | 79 |
mean arterial | 78 |
living cells | 78 |
respiratory failure | 78 |
also showed | 78 |
breast milk | 78 |
beneficial effect | 78 |
rat brain | 78 |
induced apoptosis | 78 |
particulate matter | 78 |
reactive protein | 78 |
adhesion molecule | 78 |
neuronal activity | 78 |
studies using | 77 |
metabolic acidosis | 77 |
brain barrier | 77 |
rats treated | 77 |
gibt es | 77 |
naturally occurring | 77 |
crucial role | 77 |
coronary syndrome | 77 |
coupled receptors | 77 |
gastric mucosa | 77 |
synaptic transmission | 77 |
exogenous rnas | 77 |
mit einer | 76 |
dna repair | 76 |
ca i | 76 |
insulin sensitivity | 76 |
inflammatory cytokine | 76 |
endoplasmic reticulum | 76 |
cell membranes | 76 |
peritoneal fluid | 76 |
high dose | 76 |
acute myocardial | 76 |
analysis showed | 75 |
litter size | 75 |
salivary glands | 75 |
glutathione peroxidase | 75 |
vivo studies | 75 |
patients receiving | 75 |
body temperature | 75 |
growth factors | 75 |
pulmonary disease | 75 |
large colon | 75 |
gi tract | 74 |
prospective study | 74 |
essential oil | 74 |
weight gain | 74 |
ml min | 74 |
molecular dynamics | 74 |
natural products | 74 |
vascular endothelial | 74 |
ic values | 74 |
lung tissue | 74 |
receptor activation | 74 |
virus infection | 74 |
health benefits | 74 |
gastric cancer | 74 |
significant effect | 73 |
systemic inflammatory | 73 |
poorly understood | 73 |
herbal medicine | 73 |
natural killer | 73 |
pseudomonas aeruginosa | 73 |
hek cells | 73 |
mast cell | 73 |
renal function | 73 |
mcg kg | 73 |
measured using | 73 |
pulmonary edema | 73 |
positive effects | 73 |
human beings | 73 |
congestive heart | 72 |
critical role | 72 |
hippocampal neurons | 72 |
ko mice | 72 |
zu den | 72 |
older adults | 72 |
like receptor | 72 |
cd cd | 72 |
mm hg | 72 |
every hours | 72 |
results obtained | 72 |
bowel disease | 71 |
results demonstrate | 71 |
controlled study | 71 |
fi cantly | 71 |
survival rate | 71 |
low concentrations | 71 |
thyroid hormone | 71 |
pathogenic bacteria | 71 |
key words | 71 |
antimicrobial peptide | 71 |
bovine lactoferrin | 71 |
chronic obstructive | 71 |
time pcr | 71 |
channel effects | 71 |
golgi apparatus | 71 |
within hours | 71 |
may affect | 71 |
results suggested | 71 |
molecular biology | 70 |
nigella sativa | 70 |
cell activation | 70 |
growth hormone | 70 |
nmda receptor | 70 |
increased levels | 70 |
mg dl | 70 |
ejection fraction | 70 |
determine whether | 70 |
blood mononuclear | 70 |
therapeutic agents | 70 |
male rats | 70 |
host defense | 69 |
silver nanoparticles | 69 |
inflammatory effect | 69 |
also reported | 69 |
cardiac function | 69 |
monoclonal antibodies | 69 |
transforming growth | 69 |
peritoneal macrophages | 69 |
treatment effect | 68 |
cell cultures | 68 |
many studies | 68 |
potential therapeutic | 68 |
induced oxidative | 68 |
pivotal role | 68 |
rats fed | 68 |
commercially available | 68 |
white blood | 68 |
chronic inflammatory | 68 |
cell type | 68 |
sodium bicarbonate | 68 |
physical activity | 67 |
membrane proteins | 67 |
cell wall | 67 |
blood vessels | 67 |
der geburt | 67 |
low molecular | 67 |
therapeutic potential | 67 |
pulmonary arterial | 67 |
case report | 67 |
organ dysfunction | 67 |
siehe kapitel | 67 |
target genes | 67 |
high risk | 67 |
oxygen consumption | 67 |
knee height | 66 |
nucleic acid | 66 |
protective role | 66 |
gel electrophoresis | 66 |
bei den | 66 |
abdominal pain | 66 |
older people | 66 |
study showed | 66 |
social isolation | 66 |
assay system | 66 |
protein level | 66 |
cytotoxic effects | 66 |
severe sepsis | 66 |
clinical use | 66 |
enzyme activities | 66 |
lupus erythematosus | 66 |
similar results | 66 |
human lung | 66 |
kg bw | 66 |
visual cortex | 65 |
trauma patients | 65 |
significant changes | 65 |
ventricular dysfunction | 65 |
magnetic resonance | 65 |
see table | 65 |
tumor growth | 65 |
culture medium | 65 |
binding proteins | 65 |
positive cells | 65 |
closely related | 65 |
calves fed | 64 |
neuropathic pain | 64 |
western blotting | 64 |
therapeutic effects | 64 |
term exposure | 64 |
systemic lupus | 64 |
channel blockers | 64 |
postoperative period | 64 |
upper respiratory | 64 |
myocardial ischemia | 64 |
parenteral nutrition | 64 |
seed oil | 64 |
acute renal | 64 |
passive transfer | 64 |
glucose tolerance | 64 |
zinc deficiency | 64 |
fold increase | 63 |
surface area | 63 |
brain science | 63 |
antioxidant properties | 63 |
drinking water | 63 |
drug resistance | 63 |
epithelial cell | 63 |
host cells | 63 |
study ch | 63 |
experimental animals | 63 |
increased expression | 63 |
controlled trials | 63 |
serum albumin | 63 |
major role | 62 |
last years | 62 |
real time | 62 |
cancer treatment | 62 |
neutrophil extracellular | 62 |
mw cm | 62 |
brain regions | 62 |
hemorrhagic shock | 62 |
venous blood | 62 |
ace inhibitor | 62 |
saccharomyces cerevisiae | 62 |
relatively high | 62 |
showed significant | 62 |
helicobacter pylori | 62 |
heart surgery | 62 |
different concentrations | 61 |
ischemia reperfusion | 61 |
alcohol consumption | 61 |
one must | 61 |
glucose levels | 61 |
lipid metabolism | 61 |
may require | 61 |
total protein | 61 |
mortality rates | 61 |
cells via | 61 |
vascular permeability | 61 |
food intake | 61 |
gold nanoparticles | 61 |
acute pancreatitis | 61 |
respiratory disease | 61 |
treated mice | 61 |
high level | 61 |
control groups | 60 |
und die | 60 |
outer ring | 60 |
target cells | 60 |
recombinant human | 60 |
may increase | 60 |
tract infections | 60 |
central venous | 60 |
important roles | 60 |
orally administered | 59 |
nutritional status | 59 |
ros production | 59 |
human body | 59 |
artery bypass | 59 |
patients treated | 59 |
induced liver | 59 |
mice showed | 59 |
results indicated | 59 |
systemic inflammation | 59 |
enzymatic activity | 59 |
healthy individuals | 59 |
innate immunity | 59 |
studies indicate | 59 |
genes involved | 59 |
tyrosine kinase | 59 |
low doses | 59 |
energy metabolism | 59 |
determined using | 59 |
connective tissue | 59 |
may explain | 58 |
autoimmune diseases | 58 |
also used | 58 |
gas exchange | 58 |
dose dependent | 58 |
keine hinweise | 58 |
phase ii | 58 |
inflammatory process | 58 |
chinese herbal | 58 |
ecklonia cava | 58 |
obstructive pulmonary | 58 |
prolonged exercise | 58 |
healthy controls | 58 |
time points | 58 |
air pollutants | 57 |
negatively charged | 57 |
vascular disease | 57 |
strand breaks | 57 |
cardiac index | 57 |
angiotensin converting | 57 |
biologically active | 57 |
oral cavity | 57 |
induces apoptosis | 57 |
fi cant | 57 |
artery disease | 57 |
human plasma | 57 |
patients without | 57 |
realized treatment | 57 |
gastric acid | 57 |
liver disease | 57 |
chain fatty | 57 |
der mutter | 57 |
dietary intake | 57 |
cystic fibrosis | 57 |
tumor cell | 57 |
literature review | 57 |
delivery systems | 57 |
large amounts | 56 |
significant correlation | 56 |
induced acute | 56 |
functional ingredients | 56 |
inflammatory properties | 56 |
cell function | 56 |
model system | 56 |
hepg cells | 56 |
type mice | 56 |
respiratory depression | 56 |
significantly improved | 56 |
airborne microorganisms | 56 |
acid composition | 56 |
plant ncrnas | 56 |
gastric emptying | 56 |
red wine | 56 |
left ventricle | 56 |
multiple sclerosis | 56 |
situ hybridization | 56 |
significantly inhibited | 55 |
term effects | 55 |
antioxidant status | 55 |
opioid receptor | 55 |
publications efsa | 55 |
comparative study | 55 |
eu publications | 55 |
pregnancy outcome | 55 |
potential role | 55 |
airway inflammation | 55 |
epidermal growth | 55 |
viral infection | 55 |
intravenous administration | 55 |
adult horses | 55 |
chain reaction | 55 |
growth rate | 55 |
study group | 55 |
glucose uptake | 55 |
kidney disease | 55 |
intestinal tract | 55 |
cell carcinoma | 55 |
two types | 55 |
cardiac arrest | 55 |
rat liver | 55 |
single dose | 55 |
preliminary results | 54 |
influenza pandemic | 54 |
sample size | 54 |
xanthine oxidase | 54 |
synaptic plasticity | 54 |
potential outcomes | 54 |
patients admitted | 54 |
ascorbic acid | 54 |
dairy cattle | 54 |
university graduate | 54 |
treatment group | 54 |
cortical neurons | 54 |
treated rats | 54 |
short term | 54 |
human skin | 54 |
morphological changes | 54 |
bpa exposure | 54 |
dietary supplementation | 54 |
stress response | 54 |
hepatocellular carcinoma | 54 |
oxygen delivery | 53 |
respiratory system | 53 |
human breast | 53 |
total rna | 53 |
remains unclear | 53 |
chemical composition | 53 |
also demonstrated | 53 |
milk replacer | 53 |
least one | 53 |
heat shock | 53 |
increased significantly | 53 |
coronavirus disease | 53 |
bl mice | 53 |
experimental models | 53 |
barrier function | 53 |
bovine colostrum | 53 |
fluid therapy | 53 |
male wistar | 53 |
liver function | 53 |
health status | 53 |
evidence suggests | 53 |
bronchoalveolar lavage | 53 |
calorie sweeteners | 53 |
induced diabetic | 53 |
polymerase chain | 53 |
carbon dioxide | 53 |
cells showed | 53 |
findings indicate | 53 |
cohort study | 52 |
tissue injury | 52 |
day bpa | 52 |
cell survival | 52 |
intracellular calcium | 52 |
better understanding | 52 |
plasma samples | 52 |
right ventricle | 52 |
total number | 52 |
backfire effect | 52 |
drug administration | 52 |
higher levels | 52 |
animal health | 52 |
neural stem | 52 |
data obtained | 52 |
analysis using | 52 |
activated charcoal | 52 |
mouse models | 52 |
citric acid | 52 |
endothelial function | 52 |
literature search | 52 |
chemically modified | 52 |
labor market | 52 |
medical school | 52 |
cytotoxic effect | 52 |
grocery stores | 52 |
actin cytoskeleton | 52 |
animal experiments | 52 |
related diseases | 51 |
primary pulmonary | 51 |
pilot study | 51 |
egg white | 51 |
negative effect | 51 |
depressive symptoms | 51 |
first hours | 51 |
gene silencing | 51 |
inflammatory conditions | 51 |
alter von | 51 |
glucose metabolism | 51 |
clinical study | 51 |
essential oils | 51 |
therapeutic strategies | 51 |
positive effect | 51 |
plasma protein | 51 |
receptor agonist | 51 |
kyoto university | 51 |
lymphocyte proliferation | 51 |
extracellular traps | 51 |
oxygen saturation | 51 |
mechanically ventilated | 51 |
call center | 51 |
negative effects | 51 |
common cold | 51 |
control animals | 51 |
receptor binding | 51 |
inflammatory processes | 51 |
different doses | 51 |
blood loss | 50 |
mechanisms involved | 50 |
receptor expression | 50 |
myocardial oxygen | 50 |
medical university | 50 |
ambient air | 50 |
insulin secretion | 50 |
polyunsaturated fatty | 50 |
estrogen receptor | 50 |
pomegranate seed | 50 |
protein concentration | 50 |
fruit extract | 50 |
neuronal cell | 50 |
secondary metabolites | 50 |
tidal volume | 50 |
previous study | 50 |
studies demonstrated | 50 |
osaka univ | 50 |
life sciences | 50 |
mutant mice | 50 |
randomized clinical | 50 |
alkaline phosphatase | 50 |
surgical patients | 50 |
positive correlation | 50 |
enzyme inhibition | 50 |
acid production | 50 |
acid metabolism | 50 |
conformational changes | 50 |
mitochondrial membrane | 50 |
blood gas | 50 |
clinically relevant | 50 |
congenital heart | 49 |
phase i | 49 |
systemic vascular | 49 |
fluorescence microscopy | 49 |
th day | 49 |
auf den | 49 |
cellular processes | 49 |
mouse brain | 49 |
linoleic acid | 49 |
protein kinases | 49 |
higher concentrations | 49 |
acid secretion | 49 |
fatty liver | 49 |
pharmacological effects | 49 |
takes place | 49 |
sprague dawley | 49 |
class ii | 49 |
delivery system | 49 |
experimental studies | 49 |
golgl apparatus | 49 |
human subjects | 49 |
monoclonal antibody | 49 |
high fat | 49 |
biological systems | 49 |
ii score | 49 |
early stages | 49 |
i will | 49 |
first step | 49 |
decreased significantly | 49 |
acetic acid | 49 |
systemic effects | 49 |
active molecules | 48 |
danhong injection | 48 |
room temperature | 48 |
large intestinal | 48 |
cytotoxic activity | 48 |
deleterious effects | 48 |
immunodeficiency virus | 48 |
acid residues | 48 |
adverse effect | 48 |
well established | 48 |
hulless barley | 48 |
life span | 48 |
dentate gyrus | 48 |
also studied | 48 |
effects may | 48 |
glial cells | 48 |
molecular basis | 48 |
new therapeutic | 48 |
recombinant protein | 48 |
investigated whether | 48 |
world health | 48 |
experimental data | 48 |
cell activity | 48 |
mice fed | 48 |
novel coronavirus | 48 |
antioxidant enzymes | 48 |
significant effects | 48 |
antioxidant activities | 48 |
present work | 48 |
factors affecting | 48 |
positive bacteria | 48 |
metal ions | 48 |
mice treated | 48 |
technical university | 48 |
comet assay | 48 |
control mice | 48 |
secondary structure | 47 |
toxicity studies | 47 |
biodiversity effects | 47 |
broad spectrum | 47 |
middle east | 47 |
human immunodeficiency | 47 |
chemical engineering | 47 |
propionic acid | 47 |
also shown | 47 |
different levels | 47 |
carcinoma cells | 47 |
relative humidity | 47 |
tandem mass | 47 |
adrenergic receptor | 47 |
future research | 47 |
clinical course | 47 |
beim neugeborenen | 47 |
sensory neurons | 47 |
average treatment | 47 |
therapeutic effect | 47 |
human serum | 47 |
intracellular ca | 47 |
see also | 47 |
und mitarbeiter | 47 |
animal welfare | 47 |
receptor agonists | 47 |
small rnas | 47 |
adaptive immune | 47 |
coupled receptor | 47 |
rna polymerase | 46 |
olfactory bulb | 46 |
nmda receptors | 46 |
inhaled nitric | 46 |
cycle arrest | 46 |
exogenous plant | 46 |
atopic dermatitis | 46 |
well tolerated | 46 |
direct effect | 46 |
selenium deficiency | 46 |
enzyme inhibitors | 46 |
mit einem | 46 |
per se | 46 |
years old | 46 |
statistical significance | 46 |
activated receptor | 46 |
randomised controlled | 46 |
play important | 46 |
pathological conditions | 46 |
patients suffering | 46 |
retrospective study | 46 |
scientific research | 46 |
intestinal flora | 46 |
human studies | 46 |
physiological conditions | 46 |
granule cells | 46 |
human brain | 46 |
gas chromatography | 46 |
bacillus subtilis | 46 |
intestinal microbiota | 46 |
physicochemical properties | 46 |
future studies | 46 |
pyramidal neurons | 46 |
university school | 46 |
may become | 45 |
chronic hepatitis | 45 |
cd cells | 45 |
tnf production | 45 |
creatine kinase | 45 |
response syndrome | 45 |
elderly patients | 45 |
clinical practice | 45 |
new insights | 45 |
nadph oxidase | 45 |
cells may | 45 |
terminal domain | 45 |
candida albicans | 45 |
large scale | 45 |
human colon | 45 |
gastric ulceration | 45 |
chronic heart | 45 |
early stage | 45 |
squamous cell | 45 |
herpes simplex | 45 |
antifungal activity | 45 |
growth performance | 45 |
data show | 45 |
pyramidal cells | 45 |
autophagic cell | 45 |
alveolar macrophages | 45 |
mainly due | 45 |
positive control | 45 |
inflammatory disease | 45 |
biological fluids | 45 |
candidate locations | 45 |
differentially expressed | 45 |
milk production | 45 |
possible role | 45 |
without affecting | 45 |
better understand | 45 |
anwendung von | 45 |
investigate whether | 44 |
total cholesterol | 44 |
ankara university | 44 |
combination therapy | 44 |
stroke volume | 44 |
induced cell | 44 |
ist ein | 44 |
immune cell | 44 |
coronary heart | 44 |
viral replication | 44 |
one hour | 44 |
bisher nicht | 44 |
pomegranate peel | 44 |
opioid receptors | 44 |
traditional medicine | 44 |
female rats | 44 |
membrane protein | 44 |
biological effect | 44 |
brain function | 44 |
fusion protein | 44 |
bovine viral | 44 |
signalling pathways | 44 |
hippocampal slices | 44 |
pharmacological activities | 44 |
gallic acid | 44 |
possible mechanism | 44 |
paulownia tomentosa | 44 |
metabolic pathways | 44 |
molecular level | 44 |
respiratory syncytial | 44 |
growing pigs | 44 |
three times | 44 |
induced inflammation | 44 |
phenolic acids | 44 |
calcium channels | 44 |
clostridium difficile | 44 |
among others | 44 |
ic value | 43 |
dorsal root | 43 |
investigated using | 43 |
pancreatic cancer | 43 |
dopaminergic neurons | 43 |
lactate dehydrogenase | 43 |
frequently used | 43 |
developing countries | 43 |
gnrh neurons | 43 |
experimental conditions | 43 |
adult male | 43 |
will discuss | 43 |
group compared | 43 |
trace elements | 43 |
times higher | 43 |
also increased | 43 |
chronic pain | 43 |
respiratory diseases | 43 |
pc cells | 43 |
treated animals | 43 |
systolic blood | 43 |
critical care | 43 |
highly expressed | 43 |
side effect | 43 |
well documented | 43 |
scavenging activity | 43 |
electromagnetic fields | 43 |
cell division | 43 |
data analysis | 43 |
fl ow | 43 |
liver failure | 43 |
substantia nigra | 43 |
mucosal injury | 43 |
shift work | 42 |
total antioxidant | 42 |
biochemical parameters | 42 |
bile salts | 42 |
wide variety | 42 |
kg i | 42 |
text messages | 42 |
various types | 42 |
mitochondrial dysfunction | 42 |
mediated immune | 42 |
tight junctions | 42 |
fanden sich | 42 |
will also | 42 |
im alter | 42 |
tumour necrosis | 42 |
inhibitor therapy | 42 |
might also | 42 |
food industry | 42 |
neurite outgrowth | 42 |
class i | 42 |
patients received | 42 |
mit der | 42 |
experimental model | 42 |
significant role | 42 |
creatine supplementation | 42 |
bacterial growth | 42 |
magnetic field | 42 |
authors declare | 42 |
plasma glucose | 42 |
active site | 42 |
performance liquid | 42 |
probably due | 42 |
adult rats | 42 |
dynamics simulations | 42 |
hypertensive rats | 42 |
apoptotic cell | 42 |
syncytial virus | 42 |
structural changes | 42 |
research center | 42 |
normal human | 42 |
cell biology | 42 |
genes encoding | 42 |
vascular tone | 42 |
murine model | 42 |
science institute | 42 |
cell count | 41 |
carotid artery | 41 |
proteins involved | 41 |
brain development | 41 |
elevated levels | 41 |
receptor potential | 41 |
salivary gland | 41 |
expression profiles | 41 |
antitumor activity | 41 |
backfire effects | 41 |
intervention group | 41 |
different cell | 41 |
previously shown | 41 |
patients died | 41 |
dna binding | 41 |
environment interaction | 41 |
inflammatory drugs | 41 |
organ damage | 41 |
provide evidence | 41 |
results demonstrated | 41 |
ventricular function | 41 |
pressure overload | 41 |
many cases | 41 |
four different | 41 |
action potentials | 41 |
auch bei | 41 |
metabolic disorders | 41 |
gastric ulcers | 41 |
spatial treatments | 41 |
cardiac myocytes | 41 |
cytokine release | 41 |
arginine supplementation | 41 |
university hospital | 41 |
intestinal inflammation | 41 |
examined whether | 41 |
data demonstrate | 41 |
may represent | 41 |
anticancer drugs | 41 |
expression patterns | 41 |
nasogastric tube | 41 |
abdominal surgery | 41 |
blood gases | 41 |
reporter gene | 41 |
chronic disease | 41 |
give rise | 41 |
mrna level | 41 |
bacterial translocation | 41 |
see section | 41 |
control study | 41 |
experimental study | 41 |
whole body | 41 |
rna molecules | 40 |
working memory | 40 |
gene transcription | 40 |
new york | 40 |
body fat | 40 |
blood volume | 40 |
group received | 40 |
beta blockers | 40 |
respiratory rate | 40 |
may act | 40 |
study period | 40 |
venous pressure | 40 |
peritoneal cavity | 40 |
liver tissue | 40 |
high mortality | 40 |
lipid bilayer | 40 |
human umbilical | 40 |
inflammatory markers | 40 |
stimulating factor | 40 |
direct effects | 40 |
therapie mit | 40 |
energy intake | 40 |
using different | 40 |
renal dysfunction | 40 |
high concentration | 40 |
chronic kidney | 40 |
familial mediterranean | 40 |
experimentally induced | 40 |
production systems | 40 |
barley grains | 40 |
mediterranean fever | 40 |
silica nanoparticles | 40 |
protein coupled | 40 |
fixed effects | 40 |
binding affinity | 40 |
drug interactions | 40 |
urinary tract | 40 |
fully understood | 40 |
much lower | 40 |
human milk | 40 |
whole grains | 40 |
immunomodulatory effects | 40 |
cancer risk | 40 |
low cardiac | 40 |
steady state | 40 |
vitro study | 40 |
blood levels | 40 |
interstitial pneumonia | 40 |
exogenous rna | 40 |
protein interactions | 40 |
rhodococcus equi | 40 |
lactate levels | 40 |
glycyrrhiza glabra | 40 |
ca region | 40 |
coliform bacteria | 40 |
moxa smoke | 39 |
anticancer activity | 39 |
positively correlated | 39 |
relatively low | 39 |
disease progression | 39 |
ulcerative colitis | 39 |
intestinal epithelial | 39 |
bacterial infections | 39 |
central role | 39 |
zu einer | 39 |
within days | 39 |
osaka university | 39 |
blood transfusion | 39 |
oxygen radicals | 39 |
physical examination | 39 |
early pregnancy | 39 |
inducible nitric | 39 |
studies revealed | 39 |
gram negative | 39 |
induced lung | 39 |
salmonella typhimurium | 39 |
cord injury | 39 |
health organization | 39 |
lung inflammation | 39 |
per group | 39 |
biological processes | 39 |
dna synthesis | 39 |
neurotrophic factor | 39 |
physiological functions | 39 |
basal ganglia | 39 |
related genes | 39 |
human neutrophils | 39 |
rna interference | 39 |
umbilical vein | 39 |
human intestinal | 39 |
plasma concentration | 39 |
proton pump | 39 |
olive oil | 39 |
affinity chromatography | 39 |
heavy metals | 39 |
one year | 39 |
resistance training | 39 |
environmental conditions | 39 |
intestinal absorption | 39 |
genomic dna | 38 |
mesenchymal stem | 38 |
plasma cells | 38 |
studied using | 38 |
cultured cells | 38 |
like receptors | 38 |
vitro assays | 38 |
severe cases | 38 |
intestinal metaplasia | 38 |
higher doses | 38 |
kg feed | 38 |
nk cells | 38 |
levels increased | 38 |
fl uorouracil | 38 |
poor welfare | 38 |
much higher | 38 |
vitro experiments | 38 |
scanning electron | 38 |
airway pressure | 38 |
serine protease | 38 |
transient receptor | 38 |
widely distributed | 38 |
egg production | 38 |
confocal microscopy | 38 |
cardiovascular system | 38 |
propensity score | 38 |
cell damage | 38 |
cells expressing | 38 |
recombinant proteins | 38 |
copd patients | 38 |
cordyceps militaris | 38 |
rat hippocampal | 38 |
therapeutic approach | 38 |
complement activation | 38 |
human blood | 38 |
respiratory infections | 38 |
human monocytes | 38 |
mucosal barrier | 38 |
bile acid | 38 |
tourism demand | 38 |
des fetus | 38 |
intestinal barrier | 38 |
small molecule | 38 |
novel therapeutic | 38 |
wine consumption | 38 |
via inhibition | 38 |
treated cells | 38 |
second messenger | 38 |
mediated immunity | 38 |
standard deviation | 38 |
pulmonary blood | 38 |
glutamate receptor | 38 |
bile acids | 38 |
electron microscopic | 38 |
lactic acidosis | 37 |
lavage fluid | 37 |
antiviral drugs | 37 |
reverse transcriptase | 37 |
per capita | 37 |
first days | 37 |
preclinical studies | 37 |
adult respiratory | 37 |
panel data | 37 |
protein structure | 37 |
oleic acid | 37 |
chemical constituents | 37 |
highly conserved | 37 |
total body | 37 |
cyclic amp | 37 |
ventricular hypertrophy | 37 |
two weeks | 37 |
carbon nanotubes | 37 |
group iii | 37 |
immune functions | 37 |
homo sapiens | 37 |
transit time | 37 |
free energy | 37 |
alveolar damage | 37 |
lesser extent | 37 |
spatial learning | 37 |
dietary fiber | 37 |
tissue samples | 37 |
high incidence | 37 |
brain damage | 37 |
pharmacological properties | 37 |
intravenous infusion | 37 |
bovine milk | 37 |
systemic circulation | 37 |
underlying mechanisms | 37 |
one week | 37 |
induced changes | 37 |
cell signaling | 37 |
interstitial fibrosis | 37 |
hela cells | 37 |
intestinal obstruction | 37 |
colonic mucosa | 37 |
brain tissue | 37 |
treatment groups | 37 |
protein complexes | 37 |
may produce | 37 |
thermal injury | 37 |
controlled clinical | 37 |
assessed using | 37 |
virus type | 37 |
essential role | 37 |
mehr als | 37 |
natriuretic peptide | 37 |
mice lacking | 37 |
naked sirna | 37 |
general population | 37 |
nach der | 37 |
antimicrobial agents | 36 |
double blind | 36 |
cancer stem | 36 |
regression analysis | 36 |
intestinal wall | 36 |
single cell | 36 |
take place | 36 |
serum samples | 36 |
metabolic diseases | 36 |
neonatal foals | 36 |
cardiovascular events | 36 |
complex i | 36 |
ion channel | 36 |
cerebral ischemia | 36 |
human primates | 36 |
one patient | 36 |
ii receptor | 36 |
high frequency | 36 |
adaptive immunity | 36 |
flu severity | 36 |
patients may | 36 |
turkey poults | 36 |
cells using | 36 |
normal subjects | 36 |
containing polymers | 36 |
continuous infusion | 36 |
diffuse alveolar | 36 |
tight junction | 36 |
left atrial | 36 |
herbal medicines | 36 |
infectious disease | 36 |
care units | 36 |
clinical outcome | 36 |
bronchial asthma | 36 |
gene therapy | 36 |
significantly elevated | 36 |
cytokine levels | 36 |
adverse events | 36 |
vitro model | 36 |
affected foals | 36 |
viral diarrhea | 36 |
infrared spectroscopy | 36 |
clinical evidence | 36 |
several days | 36 |
replacement therapy | 36 |
rats exposed | 36 |
controlled release | 36 |
two patients | 36 |
protein binding | 36 |
die mutter | 36 |
carbonic anhydrase | 36 |
vivo experiments | 36 |
energy transfer | 36 |
mechanical properties | 36 |
administered orally | 36 |
portal vein | 36 |
intravenous fluid | 36 |
bei einer | 35 |
ferulic acid | 35 |
chronic bronchitis | 35 |
phase response | 35 |
host cell | 35 |
degradation products | 35 |
type diabetic | 35 |
physiological role | 35 |
metabolic engineering | 35 |
years ago | 35 |
cellular immune | 35 |
old mice | 35 |
logistic regression | 35 |
marked increase | 35 |
linolenic acid | 35 |
bis zum | 35 |
punicic acid | 35 |
wild progenitors | 35 |
flow rate | 35 |
blood fl | 35 |
platelet count | 35 |
ischemic stroke | 35 |
dry weight | 35 |
still unknown | 35 |
acid bacteria | 35 |
null mice | 35 |
large amount | 35 |
hyaluronic acid | 35 |
mesenteric lymph | 35 |
gastric mucosal | 35 |
may serve | 35 |
energy expenditure | 35 |
anticancer effects | 35 |
small molecules | 35 |
pao fio | 35 |
present results | 35 |
bpa study | 35 |
two hours | 35 |
two distinct | 35 |
low concentration | 35 |
may influence | 35 |
within minutes | 35 |
human disease | 35 |
tcm formulas | 35 |
human cancer | 35 |
life expectancy | 35 |
control subjects | 35 |
bovine herpesvirus | 35 |
simplex virus | 35 |
recent research | 35 |
acid sequence | 35 |
im vergleich | 35 |
working group | 35 |
ethanol extract | 35 |
plasma proteins | 35 |
time period | 35 |
different stages | 35 |
apoptotic cells | 35 |
well understood | 35 |
another important | 35 |
also important | 35 |
chloroquine hydroxychloroquine | 35 |
increased production | 35 |
water extract | 35 |
oxygen free | 34 |
control rats | 34 |
plant extracts | 34 |
different mechanisms | 34 |
case reports | 34 |
durch die | 34 |
serum concentrations | 34 |
hemodynamic effects | 34 |
neuronal cells | 34 |
hospital stay | 34 |
cell population | 34 |
last decade | 34 |
international tourism | 34 |
glucose homeostasis | 34 |
stranded rna | 34 |
conformational change | 34 |
femoral artery | 34 |
tg mice | 34 |
high pressure | 34 |
brown algae | 34 |
cold plasma | 34 |
glutamic acid | 34 |
cell populations | 34 |
human cells | 34 |
key questions | 34 |
oxide production | 34 |
diarrhea virus | 34 |
clinical applications | 34 |
resonance imaging | 34 |
loading dose | 34 |
also significantly | 34 |
feed intake | 34 |
bacterial infection | 34 |
cardiogenic shock | 34 |
four weeks | 34 |
wealth effect | 34 |
first three | 34 |
hydroxyl radical | 34 |
digestive tract | 34 |
oral delivery | 34 |
time point | 34 |
induced colitis | 34 |
detrimental effects | 34 |
high degree | 34 |
two major | 34 |
largely unknown | 34 |
resistant starch | 34 |
biofilm formation | 34 |
mental health | 34 |
decision making | 34 |
induced dna | 34 |
teratogene effekte | 34 |
factor alpha | 34 |
small rna | 34 |
ph values | 34 |
carbon source | 34 |
proinflammatory cytokine | 34 |
fl ower | 34 |
may reduce | 34 |
intestinal motility | 34 |
cardiac fibroblasts | 34 |
cultured rat | 34 |
functional food | 34 |
allowed us | 34 |
bile duct | 34 |
intermittent fasting | 34 |
ist die | 34 |
quantitative analysis | 34 |
phase proteins | 34 |
results revealed | 34 |
treated group | 34 |
mechanism underlying | 34 |
data showed | 34 |
tohoku university | 34 |
organic acids | 34 |
hormone levels | 34 |
sensory nerves | 34 |
studies show | 34 |
dependent variable | 34 |
potential use | 34 |
stress conditions | 33 |
major surgery | 33 |
ethyl acetate | 33 |
aufgrund der | 33 |
peroxisome proliferator | 33 |
plant species | 33 |
steroid hormones | 33 |
glutamate receptors | 33 |
drug therapy | 33 |
sex differences | 33 |
electrical stimulation | 33 |
aspergillus niger | 33 |
may benefit | 33 |
transgenic mouse | 33 |
changes induced | 33 |
nerve injury | 33 |
quality control | 33 |
kyoto univ | 33 |
infected patients | 33 |
research group | 33 |
therapeutic targets | 33 |
study using | 33 |
hippocampal ca | 33 |
disease caused | 33 |
increased plasma | 33 |
chemical structure | 33 |
study revealed | 33 |
clinical effects | 33 |
bacterial cell | 33 |
term treatment | 33 |
one hand | 33 |
based attention | 33 |
dry matter | 33 |
cigarette smoke | 33 |
human volunteers | 33 |
significant change | 33 |
platelet function | 33 |
sepsis syndrome | 33 |
critical period | 33 |
ligand binding | 33 |
glioma cells | 33 |
leading cause | 33 |
disease virus | 33 |
physical exercise | 33 |
response element | 33 |
small number | 33 |
randomized trial | 33 |
study design | 33 |
different time | 33 |
underlying mechanism | 33 |
adrenergic receptors | 33 |
superoxide anion | 33 |
may involve | 33 |
consecutive days | 33 |
still unclear | 33 |
also reduced | 33 |
lymphoid tissue | 33 |
thermal stability | 33 |
calf contact | 33 |
term potentiation | 33 |
sympathetic nervous | 33 |
small colon | 33 |
two cases | 33 |
protein content | 33 |
antiviral agents | 33 |
th th | 33 |
folic acid | 33 |
mit dem | 33 |
long time | 33 |
epidemiological studies | 33 |
continuous wave | 32 |
inhibitory concentration | 32 |
urine samples | 32 |
human keratinocytes | 32 |
small amounts | 32 |
surface expression | 32 |
base balance | 32 |
inflammatory agents | 32 |
study investigated | 32 |
basement membrane | 32 |
uric acid | 32 |
pq group | 32 |
significantly correlated | 32 |
transcriptional regulation | 32 |
angiotensin system | 32 |
immune milk | 32 |
may develop | 32 |
may improve | 32 |
zusammenhang mit | 32 |
pulmonary circulation | 32 |
dependent protein | 32 |
antigen presentation | 32 |
wt mice | 32 |
beim fetus | 32 |
bovine serum | 32 |
laying hens | 32 |
goblet cells | 32 |
data collection | 32 |
flunixin meglumine | 32 |
afferent nerve | 32 |
igg concentration | 32 |
cardiovascular risk | 32 |
whole cell | 32 |
dilated cardiomyopathy | 32 |
mitochondrial function | 32 |
tohoku univ | 32 |
ovarian cancer | 32 |
nagoya university | 32 |
first trimester | 32 |
enteral nutrition | 32 |
es gibt | 32 |
pulmonary function | 32 |
three days | 32 |
chronic exposure | 32 |
study suggests | 32 |
analyzed using | 32 |
muscle mass | 32 |
population density | 32 |
free amino | 32 |
postoperative day | 32 |
human diseases | 32 |
vein endothelial | 32 |
caffeic acid | 32 |
listeria monocytogenes | 32 |
acute liver | 32 |
drug development | 32 |
negative correlation | 32 |
killer cell | 32 |
neuronal death | 32 |
cassia tora | 32 |
bypass surgery | 32 |
rats effects | 32 |
functional groups | 32 |
many different | 32 |
glandular mucosa | 32 |
poor prognosis | 32 |
induced inflammatory | 32 |
control cells | 32 |
cell differentiation | 32 |
aqueous extract | 32 |
pediatric patients | 32 |
target protein | 32 |
potent antioxidant | 32 |
also seen | 32 |
liver transplantation | 32 |
systemic blood | 32 |
may reflect | 32 |
dna adducts | 32 |
also play | 32 |
social network | 32 |
cardiovascular effects | 32 |
within min | 32 |
inflammatory reaction | 32 |
high throughput | 32 |
passive immunity | 32 |
twice daily | 32 |
surface receptors | 32 |
also contribute | 32 |
perfusion pressure | 32 |
spontaneously hypertensive | 32 |
mucosal immunity | 32 |
lipid accumulation | 32 |
recent advances | 32 |
gene regulation | 32 |
ulcer disease | 32 |
serum igg | 31 |
activating factor | 31 |
catalytic activity | 31 |
therapeutic intervention | 31 |
steroidal anti | 31 |
lung function | 31 |
culture conditions | 31 |
fluorescent protein | 31 |
activity may | 31 |
important factor | 31 |
specific antibodies | 31 |
juice consumption | 31 |
also present | 31 |
induced pulmonary | 31 |
oxidative dna | 31 |
induced activation | 31 |
primary human | 31 |
culture media | 31 |
dorsal horn | 31 |
farming systems | 31 |
map kinase | 31 |
und der | 31 |
filling pressures | 31 |
mineralocorticoid receptor | 31 |
genetically modified | 31 |
factors associated | 31 |
head injury | 31 |
single molecule | 31 |
fluid resuscitation | 31 |
may include | 31 |
inhibitory activities | 31 |
lipid bilayers | 31 |
ascending colon | 31 |
less likely | 31 |
mean values | 31 |
bei schwangeren | 31 |
organ systems | 31 |
intraperitoneal injection | 31 |
methanolic extract | 31 |
intravascular coagulation | 31 |
neural network | 31 |
projection neurons | 31 |
kg per | 31 |
rich saline | 31 |
concentration range | 31 |
antimicrobial therapy | 31 |
damage caused | 31 |
ganoderma lucidum | 31 |
functional foods | 31 |
postoperative pain | 31 |
acute inflammatory | 31 |
cognitive function | 31 |
growth cone | 31 |
female mice | 31 |
life science | 31 |
days later | 31 |
derived neurotrophic | 31 |
might contribute | 31 |
tract infection | 31 |
promoter region | 31 |
pcr analysis | 31 |
tokyo metropolitan | 31 |
healthy adult | 31 |
platelet activation | 31 |
cough reflex | 31 |
recent findings | 31 |
cellular level | 31 |
liegen keine | 31 |
placebo group | 31 |
th cells | 31 |
tissue engineering | 31 |
ventricular pacing | 31 |
ventilated patients | 31 |
functional properties | 31 |
induced arthritis | 31 |
enzymes involved | 31 |
elderly people | 31 |
broiler chickens | 31 |
ductus arteriosus | 31 |
large numbers | 31 |
lung diseases | 31 |
fluid balance | 31 |
kinase activity | 30 |
livestock production | 30 |
energy balance | 30 |
animal species | 30 |
surgical treatment | 30 |
oxygen supply | 30 |
mtt assay | 30 |
glutathione reductase | 30 |
first day | 30 |
life cycle | 30 |
induced increase | 30 |
neonatal isoerythrolysis | 30 |
promoter activity | 30 |
er stress | 30 |
ca influx | 30 |
three weeks | 30 |
social distancing | 30 |
expression pattern | 30 |
may prevent | 30 |
randomized study | 30 |
right dorsal | 30 |
skeletal muscles | 30 |
microbial community | 30 |
ag nps | 30 |
primarily informative | 30 |
glucose level | 30 |
primarily persuasive | 30 |
heat treatment | 30 |
molecular hydrogen | 30 |
disease process | 30 |
neuronal damage | 30 |
normal range | 30 |
expressing cells | 30 |
new method | 30 |
resonance energy | 30 |
leydig cells | 30 |
acid derivatives | 30 |
also show | 30 |
information processing | 30 |
low level | 30 |
new zealand | 30 |
antioxidant effect | 30 |
mesangial cells | 30 |
neural activity | 30 |
blood cultures | 30 |
liver cirrhosis | 30 |
like cells | 30 |
kg orally | 30 |
zinc oxide | 30 |
different species | 30 |
drug treatment | 30 |
general anesthesia | 30 |
mass index | 30 |
recent data | 30 |
transduction pathways | 30 |
phagocytic activity | 30 |
also cause | 30 |
obtained using | 30 |
stress induced | 30 |
pulmonary embolism | 30 |
cells compared | 30 |
fermentation process | 30 |
squamous mucosa | 30 |
induced autophagy | 30 |
social interaction | 30 |
treatment assignment | 30 |
potential effects | 30 |
cell apoptosis | 30 |
different tissues | 30 |
mobile phone | 30 |
healthy adults | 30 |
exclusive agents | 30 |
peel extract | 30 |
days post | 30 |
factor receptor | 30 |
healthy human | 30 |
tissue distribution | 30 |
often associated | 30 |
structurally related | 30 |
following treatment | 30 |
lps challenge | 30 |
part ii | 30 |
nucleus accumbens | 30 |
edema formation | 30 |
extensively studied | 30 |
may induce | 30 |
factors influencing | 30 |
four times | 30 |
gene encoding | 30 |
marketing efforts | 30 |
melanoma cells | 30 |
selenium supplementation | 30 |
mg per | 30 |
many years | 30 |
neonatal rat | 29 |
human liver | 29 |
following administration | 29 |
neuronal differentiation | 29 |
adenosine monophosphate | 29 |
veterinary medicine | 29 |
developed countries | 29 |
linear regression | 29 |
independent agents | 29 |
adverse health | 29 |
matrix metalloproteinases | 29 |
two main | 29 |
metabolic activity | 29 |
phenolic content | 29 |
high molecular | 29 |
bile salt | 29 |
liver fibrosis | 29 |
intercellular adhesion | 29 |
previously described | 29 |
size distribution | 29 |
parietal cells | 29 |
gastric ph | 29 |
growth inhibition | 29 |
clinical symptoms | 29 |
mean sd | 29 |
glycyrrhetinic acid | 29 |
active components | 29 |
will present | 29 |
respiratory infection | 29 |
well characterized | 29 |
clinical pharmacology | 29 |
human capital | 29 |
fruiting bodies | 29 |
spatial effects | 29 |
early phase | 29 |
systems biology | 29 |
milk fever | 29 |
als auch | 29 |
clinical application | 29 |
increased susceptibility | 29 |
dairy herds | 29 |
necrotizing enterocolitis | 29 |
persistent pulmonary | 29 |
negative inotropic | 29 |
neuroprotective effects | 29 |
useful tool | 29 |
pulmonary vasoconstriction | 29 |
increased pulmonary | 29 |
effective treatment | 29 |
proteolytic activity | 29 |
specific antibody | 29 |
nk cell | 29 |
arabidopsis thaliana | 29 |
data sets | 29 |
riken brain | 29 |
dna double | 29 |
fluid administration | 29 |
dairy cow | 29 |
therapeutic approaches | 29 |
autoimmune disease | 29 |
green tea | 29 |
rural areas | 29 |
shear stress | 29 |
cell lung | 29 |
related compounds | 29 |
net formation | 29 |
will provide | 29 |
releasing hormone | 29 |
creative commons | 29 |
blood supply | 29 |
infected cells | 29 |
frontal cortex | 29 |
high amounts | 29 |
adult patients | 29 |
male mice | 29 |
light intensity | 29 |
ca pyramidal | 29 |
study reported | 29 |
food additives | 29 |
antibody response | 29 |
inflammatory mediator | 29 |
elderly subjects | 29 |
kinase inhibitor | 29 |
heat stress | 29 |
tumor suppressor | 29 |
angiotensin i | 29 |
group showed | 29 |
adult humans | 29 |
matrix proteins | 29 |
neural tube | 29 |
gabe von | 29 |
spatial treatment | 29 |
related effects | 29 |
crystal structure | 28 |
immunosorbent assay | 28 |
ca concentration | 28 |
clinical experience | 28 |
oral glucose | 28 |
experiments showed | 28 |
spatial memory | 28 |
obtained results | 28 |
auditory cortex | 28 |
body fluids | 28 |
partial agonist | 28 |
functional role | 28 |
right heart | 28 |
brain stem | 28 |
one case | 28 |
septic complications | 28 |
control diet | 28 |
oxygen transfer | 28 |
three months | 28 |
synergistic effects | 28 |
peripheral nerve | 28 |
binding activity | 28 |
dendritic spines | 28 |
agaricus blazei | 28 |
nonsteroidal antiinflammatory | 28 |
artery pressure | 28 |
renal tubular | 28 |
lipid membranes | 28 |
free fatty | 28 |
cassia obtusifolia | 28 |
neurodegenerative disease | 28 |
sesquiterpene lactones | 28 |
blood lactate | 28 |
high performance | 28 |
response persistence | 28 |
evaluated using | 28 |
proteins may | 28 |
syndrome coronavirus | 28 |
likely due | 28 |
test results | 28 |
also investigated | 28 |
cerebrospinal fluid | 28 |
enzymatic hydrolysis | 28 |
endothelial growth | 28 |
organ injury | 28 |
observational study | 28 |
mixed venous | 28 |
highly sensitive | 28 |
patients showed | 28 |
lower concentrations | 28 |
pressure support | 28 |
following trauma | 28 |
muscle contraction | 28 |
peripheral vascular | 28 |
und eine | 28 |
ca release | 28 |
chemotherapeutic agents | 28 |
von der | 28 |
may reveal | 28 |
cells treated | 28 |
effect may | 28 |
immunomodulatory activity | 28 |
disseminated intravascular | 28 |
antibacterial properties | 28 |
two new | 28 |
squamous epithelium | 28 |
special reference | 28 |
molecular mass | 28 |
potent inhibitor | 28 |
disease control | 28 |
one group | 28 |
similar effects | 28 |
recently reported | 28 |
inducing apoptosis | 28 |
low risk | 28 |
case study | 28 |
positive results | 28 |
insulin levels | 28 |
showed higher | 28 |
oxygen demand | 28 |
matrix metalloproteinase | 28 |
human gut | 28 |
also detected | 28 |
key factor | 28 |
one another | 28 |
reduced expression | 28 |
programmed cell | 28 |
locomotor activity | 28 |
biological properties | 28 |
following exposure | 28 |
lipid rafts | 28 |
higher risk | 28 |
extracellular vesicles | 28 |
side chain | 28 |
human heart | 28 |
antimicrobial activities | 28 |
multiple trauma | 28 |
atrial pressure | 28 |
extracellular signal | 28 |
study found | 28 |
circular dichroism | 28 |
apoptotic effects | 28 |
oral route | 28 |
great potential | 28 |
right atrial | 28 |
health promotion | 28 |
currently available | 28 |
double strand | 28 |
exclusive agent | 28 |
factor kappa | 27 |
diabetic mice | 27 |
arterial hypertension | 27 |
defense mechanisms | 27 |
fiber die | 27 |
liver damage | 27 |
age years | 27 |
surgical procedures | 27 |
induced gastric | 27 |
disease risk | 27 |
recent evidence | 27 |
anaerobic bacteria | 27 |
human prostate | 27 |
ventricular tachycardia | 27 |
structural features | 27 |
reticulum stress | 27 |
cell numbers | 27 |
human peripheral | 27 |
clostridium perfringens | 27 |
per rectum | 27 |
small bowel | 27 |
damage induced | 27 |
schwangerschaften mit | 27 |
high glucose | 27 |
methyl ester | 27 |
specific manner | 27 |
therapy may | 27 |
inclusion criteria | 27 |
small cell | 27 |
results may | 27 |
least two | 27 |
urinary excretion | 27 |
often used | 27 |
die plazenta | 27 |
may indicate | 27 |
cell transformation | 27 |
monocytes macrophages | 27 |
ionized calcium | 27 |
strongly suggest | 27 |
expression analysis | 27 |
specific activity | 27 |
higher molar | 27 |
adrenergic stimulation | 27 |
target gene | 27 |
different conditions | 27 |
positively charged | 27 |
informed consent | 27 |
several hours | 27 |
light microscopy | 27 |
attention effect | 27 |
particular interest | 27 |
shed light | 27 |
bypass grafting | 27 |
sodium channel | 27 |
serum concentration | 27 |
dna fragmentation | 27 |
ionizing radiation | 27 |
studies also | 27 |
significantly associated | 27 |
entwicklung des | 27 |
may enhance | 27 |
supply chains | 27 |
also called | 27 |
united kingdom | 27 |
study included | 27 |
gastrointestinal disease | 27 |
wall thickness | 27 |
health problem | 27 |
flow cytometric | 27 |
ramadan fasting | 27 |
kidney injury | 27 |
zur behandlung | 27 |
markedly reduced | 27 |
cyclic nucleotide | 27 |
decreased levels | 27 |
blood serum | 27 |
hepatoprotective activity | 27 |
gabaergic neurons | 27 |
great importance | 27 |
antimicrobial properties | 27 |
cardiac failure | 27 |
acute inflammation | 27 |
therapeutic applications | 27 |
heme oxygenase | 27 |
significantly attenuated | 27 |
albino rats | 27 |
antibiotic therapy | 27 |
behandlung mit | 27 |
drug candidates | 27 |
american college | 27 |
grade inflammation | 27 |
allergic inflammation | 27 |
underlying disease | 27 |
light scattering | 27 |
chemical structures | 27 |
hepatic failure | 27 |
prenatal exposure | 27 |
epithelial barrier | 27 |
randomized double | 27 |
alzheimer disease | 27 |
gastroesophageal reflux | 27 |
genetic effects | 27 |
severe ards | 27 |
zeta potential | 27 |
clinical efficacy | 27 |
effects include | 27 |
receptive field | 27 |
current knowledge | 27 |
antioxidant effects | 27 |
obese mice | 27 |
virus replication | 27 |
mouth disease | 27 |
also occur | 27 |
organic compounds | 27 |
methanol extract | 27 |
antibiotic resistance | 27 |
spatial panel | 26 |
dietary exogenous | 26 |
endotoxic shock | 26 |
gm plants | 26 |
ldl oxidation | 26 |
angiotensin receptor | 26 |
safety profile | 26 |
immunomodulatory properties | 26 |
remained unchanged | 26 |
also confirmed | 26 |
large quantities | 26 |
volatile components | 26 |
mtor signaling | 26 |
community structure | 26 |
complement system | 26 |
chronic treatment | 26 |
vice versa | 26 |
clinical effect | 26 |
cellular responses | 26 |
inflammatory cell | 26 |
ischemic heart | 26 |
cationic amino | 26 |
dairy products | 26 |
three patients | 26 |
bei einem | 26 |
confidence intervals | 26 |
protease inhibitors | 26 |
diastolic dysfunction | 26 |
bowel syndrome | 26 |
idiopathic pulmonary | 26 |
fl owers | 26 |
biomedical applications | 26 |
major cause | 26 |
total parenteral | 26 |
gene transfer | 26 |
carbon monoxide | 26 |
muscle cell | 26 |
diffusion coefficient | 26 |
hat sich | 26 |
exercise training | 26 |
fluorescence spectroscopy | 26 |
specific protein | 26 |
significantly greater | 26 |
den fetus | 26 |
two days | 26 |
lymph node | 26 |
urine output | 26 |
auswirkungen auf | 26 |
im zusammenhang | 26 |
science foundation | 26 |
experimental group | 26 |
magnesium sulfate | 26 |
parietal cell | 26 |
ischemic injury | 26 |
cell injury | 26 |
end products | 26 |
treated patients | 26 |
crp levels | 26 |
ambient temperature | 26 |
therapeutic agent | 26 |
motor neurons | 26 |
fl uoro | 26 |
biological functions | 26 |
iron deficiency | 26 |
biological decay | 26 |
showed increased | 26 |
intestinal ischemia | 26 |
shopping outcomes | 26 |
help us | 26 |
qt prolongation | 26 |
fl uorinated | 26 |
study shows | 26 |
acid content | 26 |
studies indicated | 26 |
nude mice | 26 |
confirmed cases | 26 |
magnetic nanoparticles | 26 |
icu stay | 26 |
higher incidence | 26 |
high quality | 26 |
endotracheal tube | 26 |
neutrophil infiltration | 26 |
aortic stenosis | 26 |
molecular docking | 26 |
enteral feeding | 26 |
fi rst | 26 |
colon carcinoma | 26 |
generally accepted | 26 |
expression vector | 26 |
great depression | 26 |
advanced glycation | 26 |
refractory period | 26 |
authors concluded | 26 |
barley grass | 26 |
expression profile | 26 |
cell counts | 26 |
genetic factors | 26 |
type receptor | 26 |
oxygen tension | 26 |
acinar cells | 26 |
linked immunosorbent | 26 |
old age | 26 |
vascular endothelium | 26 |
traumatic brain | 26 |
mitral valve | 26 |
human patients | 26 |
substrate specificity | 26 |
glutamate release | 26 |
carbon tetrachloride | 26 |
significant association | 26 |
new approach | 26 |
clinical conditions | 26 |
clinical data | 26 |
fourier transform | 26 |
response curves | 26 |
using two | 26 |
also evaluated | 26 |
gastric ulcer | 26 |
dust particles | 26 |
differential expression | 26 |
evoked potentials | 26 |
antiinflammatory drugs | 26 |
ern hrung | 26 |
daily intake | 26 |
rats received | 26 |
therapeutic target | 26 |
one month | 26 |
will show | 26 |
recently identified | 26 |
metabolic activation | 26 |
powerful tool | 26 |
human diet | 26 |
anticancer drug | 26 |
several different | 26 |
effect size | 26 |
human exposure | 26 |
cells also | 26 |
elevated plasma | 25 |
soft tissue | 25 |
soybean oil | 25 |
tissue hypoxia | 25 |
low density | 25 |
dh wm | 25 |
coumaric acid | 25 |
i min | 25 |
zur anwendung | 25 |
reduced glutathione | 25 |
earlier studies | 25 |
possible mechanisms | 25 |
neurodegenerative disorders | 25 |
different effects | 25 |
nicht zu | 25 |
bioactive components | 25 |
medical sciences | 25 |
hydroxyl radicals | 25 |
dose response | 25 |
increased vascular | 25 |
biological function | 25 |
gene products | 25 |
cerebral blood | 25 |
cell infiltration | 25 |
inflammatory reactions | 25 |
various diseases | 25 |
completely abolished | 25 |
kombination mit | 25 |
functional significance | 25 |
hours later | 25 |